Pamela L. Kunz, MD

President Emerita

Medical Oncology
Yale School of Medicine

Chair, Nominating Committee,
Officer Liaison, Early Career Committee
Chair, Awards Committee

Dr. Kunz joined Yale School of Medicine from Stanford University School of Medicine where she was Director of the Stanford Neuroendocrine Tumor Program, Leader of the Endocrine Oncology Research Group, and Director of the Neuroendocrine Tumor Fellowship. At Yale, Dr. Kunz is Leader of the Gastrointestinal Cancers Program and Director of GI Medical Oncology.

Dr. Kunz specializes in the treatment of gastrointestinal malignancies. Her research involves clinical trials and epidemiologic studies, primarily in neuroendocrine and gastroesophageal cancers.

Beyond her record of accomplishments in GI Oncology, Dr. Kunz is an international leader in the clinical care of patients with neuroendocrine tumors (NETs) and is advancing the field through clinical trials and translational science that are defining the next generation of therapies for patients with this rare diagnosis.

Currently, Dr. Kunz is a pastTreasurer for the North American Neuroendocrine Tumor Society (NANETS), former chair of the Finance Committee and is a member of the Membership & Diversity Committee which she established in 2020. 

More about Dr. Kunz